(Press-News.org) Peking University, Mar 16, 2026: An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, or roughly a drop of blood. The research, published in Nature on March 4, 2026, was led by Professor He Aibin from the College of Future Technology and Professor Jing Hongmei from the Department of Hematology, PKU Third Hospital.
Why it matters
Current liquid biopsies (a type of blood test) struggle to pinpoint where disease signals originate, limiting their use. This new "cf-EpiTracing" platform overcomes that by capturing detailed epigenetic fingerprints from trace blood samples. It can identify the specific tissues driving a disease, distinguish lymphoma subtypes, and predict patient outcomes better than existing clinical tests, paving the way for earlier, more precise non-invasive diagnoses.
Key Findings
In the field of early diagnosis and screening for colorectal cancer, cf-EpiTracing has delivered impressive results. By integrating multimodal epigenomic features from cell-free chromatin and leveraging machine learning algorithms, cf-EpiTracing reaches an accuracy rate of up to 97.6% in training group samples, and remains robust at 92.2% in independent validation group samples.
In another notable discovery, the technology uncovered that patients with diffuse large B cell lymphoma exhibit stronger signals of CD34-positive cells in their plasma, potentially reflecting bone marrow involvement and disease aggressiveness. This finding offers new insights for lymphoma subtyping and treatment strategies.
Future Implications
Future directions include integrating cf-EpiTracing with other cell-free modalities such as DNA methylation, mutations, and chromatin topology. This multi-omic approach promises unprecedented precision in diagnosing complex diseases and monitoring cellular dynamics during disease progression and treatment in large patient cohorts, potentially transforming non-invasive diagnostics across multiple clinical scenarios.
*This article is featured in PKU News "Why It Matters" series. More from this series.
: https://www.nature.com/articles/s41586-026-10224-0
Written by: Jawad Shabbir
Edited by: Chen Shizhuo
Source: PKU WeChat (link)
END
Groundbreaking PKU innovation can detect disease from a drop of blood
2026-03-16
ELSE PRESS RELEASES FROM THIS DATE:
Differences in brain activity between ADHD and neurotypical adults
2026-03-16
New from JNeurosci, Elaine Pinggal, from Monash University, and colleagues assessed how sleep-like brain activity in awake adults influences sustained attention during a task.
The researchers compared sleep-like brain activity from 32 medication-withdrawn adults with ADHD to 31 neurotypical adults as participants performed a task requiring sustained attention. The ADHD group had more sleep-like brain activity, which was associated with more lapses in attention. Further analyses revealed that this activity may drive the relationship between ADHD and attention ...
How do people quickly respond to scary sounds?
2026-03-16
Preclinical studies on animals have identified brain pathways that drive quick, protective fear responses to “scary” sounds. New from JNeurosci, Emmanouela Kosteletou-Kassotaki and colleagues, from the University of Barcelona, expand on this work by exploring whether humans also have a brain pathway enabling quick fear responses to certain sounds.
Using publicly accessible data from the Human Connectome Project, the researchers examined ...
Coastal ocean chemistry now substantially shaped by humans
2026-03-16
RIVERSIDE, Calif. -- A global analysis of more than 2,300 seawater samples from more than 20 field studies around the globe indicates that human-made chemicals make up a significant portion of organic matter in coastal oceans.
The international study, led by biochemists Jarmo Kalinski and Daniel Petras at the University of California, Riverside, analyzed seawater samples collected over a decade from coastal regions from the Pacific, Atlantic, and Indian Oceans. Reported in Nature Geoscience, the findings show that ...
Brain computer interface enables rapid communication for two people with paralysis
2026-03-16
Loss of communication can be among the most devastating symptoms for patients with paralysis. A new study by investigators from Mass General Brigham Neuroscience Institute and Brown University describes an investigational implantable brain computer interface (iBCI) typing neuroprosthesis that can restore communication with speed and accuracy. The tool, which utilizes the QWERTY keyboard and attempted finger movements, performed well in two BrainGate clinical trial participants—one with amyotrophic lateral sclerosis (ALS) and the other with a cervical spinal cord injury. Their results are published ...
Computational model measures key aging metric from routine biopsies
2026-03-16
A new computational tool infers changes occurring at the ends of the chromosomes housing our DNA. It does so by detecting structural alterations in cells and tissues captured in images taken of routine medical biopsies, according to findings published March 16, 2026, in Cell Reports Methods.
Scientists at Sanford Burnham Prebys Medical Discovery Institute developed the TLPath model based on the hypothesis that modifications in the shape and structure of cells and tissues could be used to predict the length of repeating sections of DNA called ...
Geographic, racial, and sex disparities in time to treatment for early-onset colorectal cancer
2026-03-16
About The Study: This cross-sectional analysis found that delays in treatment initiation for early-onset colorectal cancer—often exceeding 90 days—were more common in all-urban populations and appeared to disproportionately affect young male, Asian or Pacific Islander, Black, or Hispanic patients. Although absolute differences in average treatment timing were modest, the focus in this study on clinically relevant delay thresholds (30, 60, and 90 days) is supported by recent meta-analytic literature. The consistency of these delays across sociodemographic groups challenges assumptions of uniformly timely access in urban settings.
Corresponding ...
Long-term trends in pediatric self-injury in high-income countries
2026-03-16
About The Study: This systematic review and meta-analysis of 42 studies observed a relative increase in the annual rate of self-injury visits to health care and self-reported self-injury among children and youth, with variability in baseline rates across studies in 12 high-income countries. Effective, contextually informed, large-scale prevention initiatives are urgently needed to curb the rise in self-injury within high-income countries, particularly among female individuals.
Corresponding Author: To contact the corresponding author, Natasha ...
Experimental therapy shows safety and signals of clinical benefit in ALS
2026-03-16
In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement and potential clinical benefits. Results of the PARADIGM study, led by researchers at Mass General Brigham Neuroscience Institute and Barrow Neurological Institute, were published in JAMA Neurology.
ALS is a progressive neurodegenerative and typically fatal disease marked by the loss of motor neurons and the gradual increase in muscle ...
Holding vs continuing GLP-1/GIP agonists before upper endoscopy
2026-03-16
About The Study: This randomized clinical trial found that continuing glucagon-like peptide-1 (GLP-1) or glucose-dependent insulinotropic polypeptide (GIP) agonist in the preprocedural period increased clinically significant residual gastric volume (RGV) but did not increase the risk of other adverse events. Clear liquids the day prior to the procedure may mitigate the risk of clinically significant RGV regardless of GLP-1/GIP use.
Corresponding Author: To contact the corresponding author, Tilak Shah, MD, MHS, email shaht3@ccf.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2026.0027)
Editor’s ...
Clinical trial results support use of weekly extended-release buprenorphine for treatment of opioid use disorder during pregnancy
2026-03-16
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder (OUD) during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue (sublingual), one of the standard methods of treatment. Additionally, serious adverse events were less common in those receiving extended-release treatment. The findings, which support the use of this formulation of buprenorphine for treating OUD during ...